Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (CA2925128) 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL BETA-D-GLUCOPYRANOSIDE ACETATE

Office : Canada
Application Number: 2925128 Application Date:
Publication Number: 2925128 Publication Date: 14.05.2015
Grant Number: Grant Date: 17.10.2017
Publication Kind : C
Prior PCT appl.: Application Number:PCTUS2014063161 ; Publication Number: Click to see the data
IPC:
C07H 17/02
A61K 31/7056
A61P 3/10
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
H
SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17
Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
02
Heterocyclic radicals containing only nitrogen as ring hetero atoms
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
70
Carbohydrates; Sugars; Derivatives thereof
7042
Compounds having saccharide radicals and heterocyclic rings
7052
having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
7056
containing five-membered rings with nitrogen as a ring hetero atom
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
CPC:
C07H 17/02
Applicants: ELI LILLY AND COMPANY
Inventors:
Priority Data: 61/901,488 08.11.2013 US
Title: (EN) 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL BETA-D-GLUCOPYRANOSIDE ACETATE
(FR) ACETATE DE 4-{4-[(1E)-4-(2,9-DIAZASPIRO[5.5]UNDEC-2-YL)BUT-1-EN-1-YL]-2-METHYLBENZYL}-5-(PROPAN-2-YL)-1H-PYRAZOL-3-YL-BETA-D-GLUCOPYRANOSIDE
Abstract: front page image
(EN) The present invention provides a compound of Formula I or hydrate thereof, useful for the treatment of diabetes.


Also published as:
UAa201603973DOP2016000067IL244899CN105705509US20160215011KR1020160067157
EA201690749EP3066108AU2014347065ID2017/05727MYPI 2016701635PH1/2016/500851
VN48279MA39019BR112016008428JP6197113TH170175IN201627009884
TN2016000112ES2703944WO/2015/069541